Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(23%)
Results Posted
71%(5 trials)

Phase Distribution

Ph phase_4
2
15%
Ph not_applicable
9
69%
Ph phase_1
1
8%
Ph phase_2
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
9(69.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
Recruiting2
unknown2
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 21 (7.7%)
Phase 42 (15.4%)
N/A9 (69.2%)

Trials by Status

recruiting215%
active_not_recruiting18%
completed754%
unknown215%
withdrawn18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13